Not all people with CLL involve therapy. Inspite of all recent improvements, the iwCLL even now recommends watchful observation for patients with asymptomatic disease.86 This recommendation is based on a minimum of two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Pemain baru pasti https://erichi433vlz9.ziblogs.com/profile